however , about 70 % of the ljp patients suffer from a defect in chemotaxis , with their neutrophils responding poorly to bacterial chemotactic factors , synthetic chemotactic peptides , and complement fragments ( c5a ) .
C0008018
chemotaxis
C1367710
c5a